U.S. Capital Wealth Advisors’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.96M Buy
243,142
+121,316
+100% +$3.53M 0.18% 142
2025
Q4
$3.45M Buy
+121,826
New +$3.44M 0.09% 238

Other funds holding REVS

U.S. Capital Wealth Advisors's REVS Position: Q1 2026 in Review

U.S. Capital Wealth Advisors increased its Columbia Research Enhanced Value ETF (REVS) stake by 100% in Q1 2026, buying an estimated $3.53M and bringing the position to 243,142 shares worth $6.96M. The position accounts for 0.18% of the portfolio, ranked #142.

U.S. Capital Wealth Advisors first reported a position in REVS in Q4 2025 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.

  • U.S. Capital Wealth Advisors held 243,142 shares of Columbia Research Enhanced Value ETF worth $6.96M as of Q1 2026.
  • U.S. Capital Wealth Advisors bought 121,316 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $3.53M.
  • Columbia Research Enhanced Value ETF made up 0.18% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #142 holding.
  • U.S. Capital Wealth Advisors first reported a position in Columbia Research Enhanced Value ETF in Q4 2025 and has held it in 2 quarters since.
  • 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.